Vaccine formulations

Details Vaccine formulations Vaccine formulations

2004-07-26

2008-05-13

Mosher, Mary E. (Department: 1648)

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

Lipid or oil

C424S204100, C424S278100

Reexamination Certificate

active

07371395

ABSTRACT:
The present invention provides for a novel oil-in-water (O/W) emulsion, with increased stability in the presence of bacterial or viral suspensions, especially those concentrated and non-purified or weakly purified. The emulsion of the present invention can act as vehicle for the delivery of a pharmaceutical composition comprising at least one immunogen and, in particular, an immunogen selected from the group comprising an inactivated pathogen, an attenuated pathogen, a subunit, a recombinant expression vector, and a plasmid or combinations thereof.

REFERENCES:
patent: 6500662 (2002-12-01), Calvert et al.
patent: 6660272 (2003-12-01), Allan et al.
patent: 6943152 (2005-09-01), Audonnet et al.
patent: 2002/0025986 (2002-02-01), Rodham et al.
patent: 1095662 (2001-05-01), None
patent: 1562758 (1969-04-01), None
patent: 2824269 (2002-11-01), None
patent: WO9956776 (1999-11-01), None
patent: WO02074283 (2002-09-01), None
Zelenay, et al. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides. Eur. J. Immunol. 2003; 33:1382-1392.
Gizurarson S, Jonsdottir VM, Heron I. Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics. Vaccine. May 1995;13(7):617-21.
Lee JM, Park KM, Lim SJ, Lee MK, Kim CK. Microemulsion formulation of clonixic acid: solubility enhancement and pain reduction. J Pharm Pharmacol. Jan. 2002;54(1):43-9.
Edelman, “An Update on Vaccine Adjuvants in Clinical Trial,” Aids Research and Human Retroviruses 8(8):1409-1411 (1992).
McElrath, “Selection of potent immunological adjuvants for vaccine construction,” seminars in Cancer Biology 6:375-385 (1995).
Aucouturier et al., “Adjuvants designed for veterinary and human vaccines,” Vaccine 19:2666-2672 (2001).
East et al., “Adjuvants for New Veterinary Vaccines,” Chapter 1 in Progress in Vaccinology, vol. 4 Veterinary Vaccines, Springer Verlag, NY 1993, pp. 1-28.
Altman et al., “Immunomodifiers in Vaccines,” Advances In Veterinary Science and Comparative Medicine 33:301-343 (1989).
Wiilson et al., “Tissue Reaction and Immunity in Swine Immunized withActinobacillus pleuropneumoniaeVaccines,” Can J Vet Res 59:299-305 (1995).

Affiliated with

Also associated with

Rating

Vaccine formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Vaccine formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3985932